Ignite Creation Date:
2024-05-06 @ 10:53 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03376503
Status:
COMPLETED
Last Update Posted:
2017-12-19
First Post:
2017-12-12
Brief Title:
Nanogen Pegfilgrastim Pegcyte PKPD Clinical Study in Breast Cancer Patients
Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization Data
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Class:
INDUSTRY
Study ID:
NNG04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None